Success Story: NIW Approval for a Biostatistics Expert Advancing Evidence-Based Healthcare Research
Client’s Testimonial:
"Excellent work, very efficient and proactive. Thank you!”
On April 16th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Fellow in the Field of Biostatistics (Approval Notice).
General Field: Biostatistics
Position at the Time of Case Filing: Fellow
Country of Origin: China
State of Residence at the Time of Filing: Maryland
Approval Notice Date: April 16th, 2026
Processing Time: 12 months, 19 days (Premium Processing Upgrade Requested)
Case Summary:
A Ph.D. in biostatistics secured approval of the I-140 NIW petition after presenting a strong record of research in clinical trial design, real-world data analysis, and evidence-based healthcare decision-making. The client is currently employed as a postdoctoral fellow and continues to apply statistical methodologies to clinical data in order to improve health knowledge, inform medical decisions, and support better patient outcomes.
The Client’s Work in Biostatistics
The client’s proposed endeavor focused on advancing and applying statistical methodologies to design clinical trials and obtain evidence-based insights from real-world data. Rather than presenting this work as a narrow academic pursuit, the petition framed it as a nationally important effort tied to better clinical trial optimization, improved early diagnostic tools, and more reliable healthcare decision-making.
The petition also explained how the client’s current work applies this expertise to clinical trial and natural history study data, including research connected to specific health disorders. This helped show that the client’s endeavor was both ongoing and connected to practical healthcare needs in the United States.
Evidence of Research Excellence
To demonstrate that the client was well-positioned to advance the proposed endeavor, the petition highlighted 7 peer-reviewed journal articles, including 1 first-authored article, and 3 conference abstracts, including 2 first-authored abstracts. These publications were not treated as numbers alone. Instead, the petition explained that publication in recognized venues showed peer evaluation of the quality and relevance of the client’s work.
The client’s publications had also received 47 citations. The petition interpreted these citations as evidence that independent researchers had relied on the client’s findings in areas such as specific health disorder management, delivery risk analysis, infectious disease diagnostics, and machine learning applications in healthcare.
National Importance and Independent Recognition
The petition further emphasized that the client’s research had received support from the National Institute of Nursing Research. This funding support served as an external credibility marker, showing that the work aligned with broader healthcare research priorities and was not merely of private or localized benefit.
By connecting the client’s publication record, citation history, funded research, and ongoing work to the national need for improved clinical trial design and evidence-based healthcare insights, the petition demonstrated both the importance of the endeavor and the client’s strong positioning to continue advancing it.
NIW Approval and Outlook
The I-140 NIW approval recognized the strength of the client’s biostatistics background, research productivity, independent scholarly influence, and continued commitment to healthcare-focused statistical research. We congratulate the client on this important approval and wish the client continued success in advancing evidence-based methods that can support stronger healthcare decisions and improved patient outcomes in the United States.